Company: PFSA
Filing Date: 2025-02-12
Form Type: S-4/A
Source: 0001213900-25-012354
Chunk: 485

Company: Profusa, Inc.
Filing Date: 2025-02-12
Form: S-4/A
Chunk 485
---
 administration of its risk oversight function has not negatively affected our board of directors’ leadership structure. Code of Ethics New Profusa’s Board will adopt a Code of Ethics applicable to our directors, executive officers and team members that complies with the rules and regulations of Nasdaq and the SEC. The Code of Ethics will be available on New Profusa’s website. In addition, New Profusa intends to post on the Corporate Governance section of its website all disclosures that are required by law or Nasdaq listing standards concerning any amendments to, or waivers from, any provision of the Code of Ethics. The reference to New Profusa’s website address in this proxy statement/prospectus does not include or incorporate by reference the information on New Profusa’s website into this proxy statement/prospectus. Compensation of Directors and Officers Following the Closing of the Business Combination, we expect New Profusa’s executive compensation program to reflect Profusa’s compensation policies and philosophies, as they may be modified and updated from time to time. Following the Closing of the Business Combination, we expect that decisions with respect to the compensation of our executive officers, including our named executive officers, will be made by the compensation committee of the New Profusa Board. Profusa’s executive compensation programs for [2023] are further described above under “ Management of Profusa — Profusa Executive Compensation” and “ Management of Profusa — Profusa Director Compensation.” Description of EIS and ESPP Plans New Profusa will establish a 2025 equity incentive plan and 2025 employee stock purchase plan. Information about the plans will be disclosed in a subsequent filing prior to the consummation of the Business Combination. 284

SHARES ELIGIBLE FOR FUTURE SALE Upon the Closing, New Profusa will have 300,000,000shares of New Profusa Common Stock authorized. The following summarizes the pro forma shares of New Profusa Common Stock issued and outstanding immediately after the Business Combination, presented under the two redemption scenarios listed:

|                                                                                                   |     | Pro Forma Combined 
       (Assuming No 
       Redemptions) |     |       |     | Pro Forma Combined 
  (Assuming Maximum 
    Redemptions)(1) |     |       |
| Shareholder                                                                                       |     |             Shares |     |     % |     |             Shares |     |     % |
| NorthView public shareholders(4)                                                                  |     |          2,585,019 |     |   7.7 |     |          2,319